Brookmont Catastrophic Bond ETF gives investors access to catastrophe bonds with 8% yield, diversification, and low correlation. Learn why ILS ETF is a buy.

Rishab Shetty's 'Kantara: Chapter 1' is dominating the box office, surpassing Rs 430 crore after its second weekend. The film showed strong growth, outperforming 'Sunny Sanskari Ki Tulsi Kumari' ...

Rishab Shetty's 'Kantara: Chapter 1' has achieved historic box office success, becoming the highest-grossing film ever in Karnataka and nearing ₹200 crore in the state alone. The film's nationwide ...

Xiaomi launched the Redmi Note 15 series in China in August, which comprises the Note 15, Note 15 Pro, and Note 15 Pro+. Now, the brand is gearing up to launch the Note 15 series phones soon in the ...

A ONE-of-a-kind £5 banknote has sold for an astonishing price at auction – nearly 5,000 times its face value. The highly unusual Bank of England note was printed in Birmingham in 1892 and signed by ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

Disclaimer: The content presented here is for entertainment purposes only and does not guarantee the authenticity or accuracy of the information. The content may contain elements of fiction, ...

Lawrence Stroll has always been an enigma. The Globe and Mail’s first mention of him was in 1990, in a story about the Canadian launch of Tommy Hilfiger’s menswear collection. Stroll is named as ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

Onyx Boox has just released its latest generation color e-notebook, the Note Air 5C. It is using an older-generation Carta 1200 display instead of the latest-gen 1300 panel. However, it uses the same ...

Cancer biotech Vivace Therapeutics is tuning up for a phase 3 trial after its potential first-in-class small molecule scored a 32% objective response rate in patients with treatment-resistant ...